Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis

Table 3 Comparison of hepatic ALB mRNA and liver Ki67 labeling index

Normal control group (n = 12)		PN group (n = 12)			rhGH+PN group (n = 12)
		Tumor tissues	Adjacent non-tumor tissues	Liver biopsy specimens POD 6	Tumor tissue	Adjacent non-tumor tissues	Liver biopsy specimens POD 6
ALB mRNA	0.69 ± 0.05	0.38 ± 0.01a	0.50 ± 0.06ac	0.63 ± 0.05	0.38 ± 0.01a	0.50 ± 0.06ac	0.71 ± 0.06e
Liver Ki67 LI (%)	0	17.4 ± 6.1a	0.20 ± 0.1ac	4.60 ± 0.5	17.2 ± 5.9a	0.20 ± 0.1ac	5.50 ± 0.5e

^aP < 0.05, tumor tissues or adjacent non-tumor tissues vs normal control group;

^cP < 0.05, adjacent non-tumor tissues vs tumor tissues in the same group,

^eP < 0.05, of the same tissues comparison between the PN group and rhGH + PN group.